For information about most clinical trials in cancer, please see our special cancer clinical trials database. Other open trials may be listed below. If you have questions about clinical trials in cancer, call Laurie Smith, director of research, Division of Hematology/Oncology, at (312) 942-8312.
Included in this section:
Brachytherapy for Early Stage Breast Cancer: Clinical study to evaluate the safety and performance of the Axxent electronic brachytherapy system in women with resected, early stage breast cancer
Favorable-Risk Prostate Cancer Study: RTOG 0415: A phase III randomized study of hypofractionated 3D-CRT/IMRT versus conventionally fractionated 3D-CRT/IMRT in patients with favorable-risk prostate cancer
Intermediate Risk Prostatic Cancer Study: RTOG 0232: A phase III study comparing combined external beam radiation and transperineal interstitial prmanent brachytherapy with brachytherapy alone for selected patients with intermediate risk prostatic cancer
Locally Advanced Rectal Cancer: Randomized phase II trial of neoadjuvant combined modality therapy for locally advanced rectal cancer
Prostate Cancer Study: Phase 3, double blind trial, using investigational product in asymptomatic subjects with Gleason sum equal to or lesser than 7, metastatic androgen independent prostatic adenocarcinoma
Prostate Carcinoma Study: Helical tomotherapy treatment of dominant intraprostatic lesions in patients with prostate carcinoma utilizing magnetic resonance imaging and spectroscopic guidance